| Year |
Title |
Altmetric |
| 2018
|
Wnt receptor Frizzled 8 is a target of ERG in prostate cancer.
Prostate.
78:1311-1320.
2018
|
|
| 2018
|
Detection of BRAF V600E mutations with next-generation sequencing in infarcted thyroid carcinomas after fine-needle aspiration.
American Journal of Clinical Pathology.
150:177-185.
2018
|
|
| 2018
|
Single molecule mtDNA fiber FISH for analyzing numtogenesis.
Analytical Biochemistry.
552:45-49.
2018
|
|
| 2018
|
miR-34a regulates expression of the stathmin-1 oncoprotein and prostate cancer progression.
Cell Growth and Differentiation.
16:1125-1137.
2018
|
|
| 2018
|
Hsp70 and gama-Semino protein as possible prognostic marker of prostate cancer.
Frontiers in Bioscience.
23:1987-2000.
2018
|
|
| 2018
|
Prostate cancer health disparities: An immuno-biological perspective.
Cancer Letters.
414:153-165.
2018
|
|
| 2017
|
Bromoethylindole (BEI-9) redirects NF-κB signaling induced by camptothecin and TNFα to promote cell death in colon cancer cells.
Apoptosis.
22:1553-1563.
2017
|
|
| 2017
|
Prolonged exposure of resveratrol induces reactive superoxide species–independent apoptosis in murine prostate cells.
Tumor Biology.
39:1-10.
2017
|
|
| 2017
|
Label-free detection of DNA hybridization with a compact LSPR-based fiber-optic sensor.
Analyst.
142:1974-1981.
2017
|
|
| 2017
|
Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.
Oncotarget.
8:76574-76586.
2017
|
|
| 2017
|
Molecular characterization of pro-metastatic functions of β4- integrin in colorectal cancer.
Oncotarget.
8:92333-92345.
2017
|
|
| 2017
|
Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Oncotarget.
8:20198-20212.
2017
|
|
| 2017
|
Resveratrol induces mitochondria-mediated, caspaseindependent apoptosis in murine prostate cancer cells.
Oncotarget.
8:20895-20908.
2017
|
|
| 2016
|
Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.
Current Colorectal Cancer Reports.
12:332-344.
2016
|
|
| 2016
|
A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.
BMC Cancer.
16.
2016
|
|
| 2016
|
Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.
Cancer Letters.
374:304-314.
2016
|
|
| 2016
|
Targeting Hsp70: A possible therapy for cancer.
Cancer Letters.
374:156-166.
2016
|
|
| 2016
|
Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas..
J Dig Dis Hepatol.
2016.
2016
|
|
| 2015
|
Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in acolon-26 tumor-bearing mouse model in vivo.
Cancer Medicine.
4:1767-1780.
2015
|
|
| 2015
|
3-(2-bromoethyl)-indole inhibits the growth of cancer cells and NF-κB activation.
Oncology Reports.
34:495-503.
2015
|
|
| 2015
|
Clinical implications of rabphillin-3A-like gene alterations in breast cancer.
PLoS ONE.
10.
2015
|
|
| 2015
|
IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.
Bioorganic and Medicinal Chemistry.
23:602-611.
2015
|
|
| 2015
|
Nanomagnetic levitation three-dimensional cultures of breast and colorectal cancers.
Journal of Surgical Research.
194:319-326.
2015
|
|
| 2015
|
Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers.
Oncotarget.
6:27763-27777.
2015
|
|
| 2014
|
Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model.
PLoS ONE.
9.
2014
|
|
| 2014
|
Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.
BMC Cancer.
14.
2014
|
|
| 2014
|
A New Robust Method for Nonlinear Regression..
Journal of Biometrics and Biostatistics.
5:211.
2014
|
|
| 2014
|
Robust Logistic and Probit Methods for Binary and Multinomial Regression..
Journal of Biometrics and Biostatistics.
5.
2014
|
|
| 2013
|
The Chemokine CXCL8 in Carcinogenesis and Drug Response..
ISRN Oncology.
2013:859154.
2013
|
|
| 2013
|
Clinical implications of microRNAs in cancer.
Stain technology.
88:388-396.
2013
|
|
| 2013
|
Post-transcriptional processing of genetic information and its relation to cancer.
Stain technology.
88:365-372.
2013
|
|
| 2013
|
The prognostic value of MicroRNAs varies with patient race/ethnicity and stage of colorectal cancer.
Clinical Cancer Research.
19:3955-3965.
2013
|
|
| 2013
|
Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer..
Journal of Cancer Therapy.
4:898-906.
2013
|
|
| 2013
|
Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
Stain technology.
88:38-46.
2013
|
|
| 2013
|
Socioeconomic status, p53 abnormalities, and colorectal cancer.
Journal of Gastrointestinal Oncology.
4:40-44.
2013
|
|
| 2012
|
Pseudoangiomatous stromal hyperplasia (PASH) of the breast: A series of 24 patients.
Breast Journal.
18:242-247.
2012
|
|
| 2012
|
Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable Stage III colorectal adenocarcinomas.
PLoS ONE.
7.
2012
|
|
| 2012
|
Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: The role of rs67491583.
Cancer Genetics.
205:25-33.
2012
|
|
| 2012
|
Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.
Anticancer Research.
32:61-71.
2012
|
|
| 2012
|
MiRNAs are stable in colorectal cancer archival tissue blocks.
Frontiers in bioscience (Elite edition).
4 E:1937-1940.
2012
|
|
| 2011
|
Development and progression of colorectal neoplasia.
Cancer Biomarkers.
9:235-265.
2011
|
|
| 2011
|
The biology of incipient, pre-invasive or intraepithelial neoplasia.
Cancer Biomarkers.
9:21-39.
2011
|
|
| 2011
|
Translational pathology of neoplasia.
Cancer Biomarkers.
9:7-20.
2011
|
|
| 2011
|
Development and independent validation of a prognostic assay for stage ii colon cancer using formalin-fixed paraffin-embedded tissue.
Journal of Clinical Oncology.
29:4620-4626.
2011
|
|
| 2011
|
Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer.
Journal of Hematology & Oncology.
4.
2011
|
|
| 2011
|
Erratum: Development of combination tapered fiber-optic biosensor dip probe for quantitative estimation of interleukin-6 in serum samples (Journal of Biomedical Optics (2010) 15 (067005)).
Journal of Biomedical Optics.
16.
2011
|
|
| 2010
|
Bax expression is a candidate prognostic and predictive marker of colorectal cancer..
Journal of Gastrointestinal Oncology.
1:76-89.
2010
|
|
| 2010
|
Development of combination tapered fiber-optic biosensor dip probe for quantitative estimation of interleukin-6 in serum samples.
Journal of Biomedical Optics.
15.
2010
|
|
| 2010
|
Standards for immunohistochemical imaging: A protein reference device for biomarker quantitation.
Journal of Histochemistry and Cytochemistry.
58:1005-1014.
2010
|
|
| 2010
|
MiRNAs as biomarkers for management of patients with colorectal cancer.
Biomarkers in Medicine.
4:761-770.
2010
|
|
| 2010
|
Prognostic value of mucin 4 expression in colorectal adenocarcinomas.
Cancer.
116:3577-3586.
2010
|
|
| 2010
|
Comparison of the predictive qualities of three prognostic models of colorectal cancer.
Frontiers in bioscience (Elite edition).
2 E:849-856.
2010
|
|
| 2010
|
Quantitative estimation of IL-6 in serum/plasma samples using a rapid and cost-effective fiber optic dip-probe.
Progress in Biomedical Optics and Imaging - Proceedings of SPIE.
7559.
2010
|
|
| 2010
|
Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
Cancer Research.
70:968-978.
2010
|
|
| 2009
|
Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer.
Cancer.
115:5798-5806.
2009
|
|
| 2009
|
HIV Nef-M1 effects on colorectal cancer growth in tumor-induced spleens and hepatic metastasis.
Molecular and Cellular Pharmacology.
1:85-91.
2009
|
|
| 2009
|
Combined effects of formalin fixation and tissue processing on immunorecognition Fixation effects on immunostaining.
Stain technology.
84:223-247.
2009
|
|
| 2009
|
Combined effects of formalin fixation and tissue processing on immunorecognition..
Stain technology.
84:223-247.
2009
|
|
| 2009
|
Furthering the evidence-based management of dermatologic effects of EGFR inhibitor therapy.
Current Colorectal Cancer Reports.
5:179-181.
2009
|
|
| 2009
|
Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer.
Journal of Clinical Oncology.
27:4339-4345.
2009
|
|
| 2009
|
Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of Merkel cell carcinoma and its correlation with prognosis..
Journal of Clinical Oncology.
27:6027.
2009
|
|
| 2009
|
Prognostic significance of VDR, DKK-1, and DKK-4 expression in colorectal cancer..
Journal of Clinical Oncology.
27:e15047.
2009
|
|
| 2009
|
Prognostic significance of p53 Codon 72 polymorphism differs with race in colorectal adenocarcinoma.
Clinical Cancer Research.
15:2406-2416.
2009
|
|
| 2009
|
Immunohistochemical expression of rabphilin -3A-like (Noc2) in normal and tumor tissues of human endocrine pancreas.
Stain technology.
84:39-45.
2009
|
|
| 2008
|
Clinical significance of a novel single nucleotide polymorphism in the 5′ untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.
Frontiers in Bioscience.
13:1050-1061.
2008
|
|
| 2008
|
Lynch syndrome in women less than 50 years of age with endometrial cancer.
Obstetrics and Gynecology.
111:1161-1166.
2008
|
|
| 2008
|
p53 nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior.
Journal of Histochemistry and Cytochemistry.
56:305-312.
2008
|
|
| 2007
|
Comparison of predicted probabilities of proportional hazards regression and linear discriminant analysis methods using a colorectal cancer molecular biomarker database.
Cancer Informatics.
3:115-122.
2007
|
|
| 2007
|
Methionine inhibits cellular growth dependent on the p53 status of cells.
American Journal of Surgery.
193:274-283.
2007
|
|
| 2007
|
African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: An epidemiologic review.
Cancer Biomarkers.
3:301-313.
2007
|
|
| 2007
|
Predicting 5-year survival of colorectal carcinoma patients using data mining methods..
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium.
907.
2007
|
|
| 2007
|
Understanding racial differences in colorectal cancer aids in individualized medicine.
Future Oncology.
3:235-241.
2007
|
|
| 2006
|
Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates..
American Journal of Clinical Pathology.
126:572-579.
2006
|
|
| 2006
|
Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Archives of Pathology and Laboratory Medicine.
130:1510-1515.
2006
|
|
| 2006
|
Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer..
Journal of Clinical Oncology.
24:3605.
2006
|
|
| 2006
|
Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates: A translational research application.
American Journal of Clinical Pathology.
126:572-579.
2006
|
|
| 2006
|
Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
Critical Reviews in Oncology/Hematology.
60:9-18.
2006
|
|
| 2005
|
The need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis.
Cancer Informatics.
1:86-97.
2005
|
|
| 2005
|
Keynote review: Recent advances in biomarkers for cancer diagnosis and treatment.
Drug Discovery Today.
10:965-976.
2005
|
|
| 2005
|
High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.
Cancer.
103:2163-2170.
2005
|
|
| 2005
|
Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
Cancer Biomarkers.
1:241-250.
2005
|
|
| 2004
|
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma [2] (multiple letters).
Cancer.
101:2899-2900.
2004
|
|
| 2004
|
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma.
Cancer.
101:66-76.
2004
|
|
| 2004
|
Prognostic Significance of p27kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage.
Clinical Cancer Research.
10:1743-1752.
2004
|
|
| 2003
|
MUC1 and MUC2 Expression in Pancreatic Ductal Carcinoma Obtained by Fine-Needle Aspiration.
Cancer.
99:365-371.
2003
|
|
| 2003
|
The efficacy of 9-Cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: Results of a randomized double-blind clinical trial.
Cancer Epidemiology, Biomarkers and Prevention.
12:114-119.
2003
|
|
| 2003
|
Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.
Chest.
123:181-186.
2003
|
|
| 2002
|
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
Clinical Cancer Research.
8:734-744.
2002
|
|
| 2002
|
Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: A sensitive method for assessing 5-fluorocytosine toxicity in Vitro.
Analytical Biochemistry.
301:189-199.
2002
|
|
| 2002
|
Molecular staging of colorectal cancer in African-American and caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 and p27kip-1.
International Journal of Cancer.
97:403-409.
2002
|
|
| 2001
|
Altered subcellular localization of Suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
Clinical Cancer Research.
7:3495-3503.
2001
|
|
| 2001
|
Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers..
Federation proceedings.
15:A249-A249.
2001
|
|
| 2001
|
Molecular characterization of colorectal neoplasia in translational research.
Archives of Pathology and Laboratory Medicine.
125:91-98.
2001
|
|
| 2001
|
Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Laryngoscope.
111:1373-1378.
2001
|
|
| 2000
|
Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Clinical Cancer Research.
6:4017-4025.
2000
|
|
| 2000
|
BC1-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
International Journal of Cancer.
89:423-430.
2000
|
|
| 2000
|
Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas..
International Journal of Cancer.
89:423-430.
2000
|
|
| 2000
|
Elevated expression of fatty acid synthase (FASE) in squamous cell cancer of the lung..
Federation proceedings.
14:A789-A789.
2000
|
|
| 2000
|
Immunohistochemical evaluation of global DNA methylation: Comparison with in vitro radiolabeled methyl incorporation assay.
Stain technology.
75:251-258.
2000
|
|
| 2000
|
The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
Human Pathology.
31:482-487.
2000
|
|
| 2000
|
The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.
Human Pathology.
31:1068-1073.
2000
|
|
| 1999
|
Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma.
International Journal of Cancer.
82:424-429.
1999
|
|
| 1999
|
Evaluation of biomarker modulation by fenretinide in prostate cancer patients.
European Urology.
35:429-438.
1999
|
|
| 1999
|
Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma.
Journal of Urology, The.
161:945-949.
1999
|
|
| 1999
|
Ep-CAM levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Journal of Urology, The.
162:1462-1466.
1999
|
|
| 1998
|
Nuclear accumulation of p53 in colorectal adenocarcinoma prognostic importance differs with race and location of the tumor.
Cancer.
83:2456-2467.
1998
|
|
| 1997
|
Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.
International Journal of Cancer.
74:346-358.
1997
|
|
| 1997
|
Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer..
JNCI: Journal of the National Cancer Institute.
89:585-586.
1997
|
|
| 1997
|
The use of biomarker expression to characterize neoplastic processes.
Stain technology.
72:96-104.
1997
|
|
